ShouTi Company
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Industry:
Early Drug Development
Headquarters:
South San Francisco, California, United States
Founded Date:
2016-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
18
Total Funding:
207000000
Last Funding Date:
2021-10-20
Last Funding Type:
Series B
Register and Claim Ownership